A comparison of anatomic and cellular transcriptome structures across 40 human brain diseases

Genes associated with risk for brain disease exhibit characteristic expression patterns that reflect both anatomical and cell type relationships. Brain-wide transcriptomic patterns of disease risk genes provide a molecular-based signature, based on differential co-expression, that is often unique to that disease. Brain diseases can be compared and aggregated based on the similarity of their signatures which often associates diseases from diverse phenotypic classes. Analysis of 40 common human brain diseases identifies 5 major transcriptional patterns, representing tumor-related, neurodegenerative, psychiatric and substance abuse, and 2 mixed groups of diseases affecting basal ganglia and hypothalamus. Further, for diseases with enriched expression in cortex, single-nucleus data in the middle temporal gyrus (MTG) exhibits a cell type expression gradient separating neurodegenerative, psychiatric, and substance abuse diseases, with unique excitatory cell type expression differentiating psychiatric diseases. Through mapping of homologous cell types between mouse and human, most disease risk genes are found to act in common cell types, while having species-specific expression in those types and preserving similar phenotypic classification within species. These results describe structural and cellular transcriptomic relationships of disease risk genes in the adult brain and provide a molecular-based strategy for classifying and comparing diseases, potentially identifying novel disease relationships.

[1]  Michael F. Green,et al.  Mapping genomic loci implicates genes and synaptic biology in schizophrenia , 2022, Nature.

[2]  M. Olive,et al.  Drugs of Abuse Differentially Alter the Neuronal Excitability of Prefrontal Layer V Pyramidal Cell Subtypes , 2021, Frontiers in Cellular Neuroscience.

[3]  J. Concato,et al.  Bi-Ancestral Depression GWAS in the Million Veteran Program and Meta-Analysis in >1.2 Million Subjects Highlights New Therapeutic Directions , 2021, Nature Neuroscience.

[4]  J. Mandel,et al.  The concurrence of multiple sclerosis and glioblastoma. , 2021, Multiple sclerosis and related disorders.

[5]  Ryan J H West,et al.  Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis , 2020, Neurobiology of Disease.

[6]  Saskia E. J. de Vries,et al.  VIP interneurons in mouse primary visual cortex selectively enhance responses to weak but specific stimuli , 2020, eLife.

[7]  P. Kharchenko,et al.  Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis , 2020, Nature Communications.

[8]  D. Goldstein,et al.  Expansion of the GRIA2 phenotypic representation: a novel de novo loss of function mutation in a case with childhood onset schizophrenia , 2020, Journal of Human Genetics.

[9]  Howard Y. Chang,et al.  The road ahead in genetics and genomics , 2020, Nature Reviews Genetics.

[10]  D. Geschwind,et al.  Transcriptomic and cellular decoding of regional brain vulnerability to neurogenetic disorders , 2020, Nature Communications.

[11]  S. Liebscher,et al.  Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology , 2020, Frontiers in Neuroscience.

[12]  S. Carmichael,et al.  Glia in neurodegeneration: Drivers of disease or along for the ride? , 2020, Neurobiology of Disease.

[13]  G. Trynka,et al.  From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases , 2020, Frontiers in Genetics.

[14]  Kyle J. Gaulton,et al.  An atlas of gene regulatory elements in adult mouse cerebrum , 2020, Nature.

[15]  Monika S. Kowalczyk,et al.  Systematic comparison of single-cell and single-nucleus RNA-sequencing methods , 2020, Nature Biotechnology.

[16]  Hongkui Zeng,et al.  A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation , 2020, Cell.

[17]  E. Westman,et al.  Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease , 2020, Neurobiology of Disease.

[18]  Christina F. Chick,et al.  Identification of Common Neural Circuit Disruptions in Emotional Processing Across Psychiatric Disorders. , 2020, The American journal of psychiatry.

[19]  Yuedong Yang,et al.  Identifying Common Genes, Cell Types and Brain Regions Between Diseases of the Nervous System , 2019, Front. Genet..

[20]  F. Sanz,et al.  The DisGeNET knowledge platform for disease genomics: 2019 update , 2019, Nucleic Acids Res..

[21]  Matthew Hur,et al.  Dopamine Deficiency Reduces Striatal Cholinergic Interneuron Function in Models of Parkinson’s Disease , 2019, Neuron.

[22]  Allan R. Jones,et al.  Conserved cell types with divergent features in human versus mouse cortex , 2019, Nature.

[23]  Jie Li,et al.  Application of Computational Biology to Decode Brain Transcriptomes , 2019, Genom. Proteom. Bioinform..

[24]  Ethan M. Goldberg,et al.  Vasoactive intestinal peptide-expressing interneurons are impaired in a mouse model of Dravet syndrome , 2019, eLife.

[25]  Sojib Bin Zaman,et al.  Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. , 2017, The Lancet. Neurology.

[26]  William M Carroll,et al.  The global burden of neurological disorders , 2019, The Lancet Neurology.

[27]  Ellis Patrick,et al.  Deconvolving the contributions of cell-type heterogeneity on cortical gene expression , 2019, bioRxiv.

[28]  Alexandra K. Gold,et al.  Treating Circadian Rhythm Disruption in Bipolar Disorder , 2019, Current Psychiatry Reports.

[29]  R. Moyeed,et al.  Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease , 2019, Molecular Brain.

[30]  V. Vacic,et al.  Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.

[31]  Stephan J Sanders,et al.  Integrative functional genomic analysis of human brain development and neuropsychiatric risks , 2018, Science.

[32]  Herng‐Ching Lin,et al.  Association of migraines with brain tumors: a nationwide population-based study , 2018, The Journal of Headache and Pain.

[33]  Charles E. Dean,et al.  Neural circuitry and precision medicines for mental disorders: are they compatible? , 2018, Psychological Medicine.

[34]  Gregory J. Hunt,et al.  Dtangle: Accurate and Robust Cell Type Deconvolution , 2018, Bioinform..

[35]  Manoj Kumar,et al.  Linking spatial gene expression patterns to sex-specific brain structural changes on a mouse model of 16p11.2 hemideletion , 2018, Translational Psychiatry.

[36]  D. Vieau,et al.  Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism , 2018, Front. Mol. Neurosci..

[37]  H. van Bokhoven,et al.  Inhibitory control of the excitatory/inhibitory balance in psychiatric disorders , 2018, F1000Research.

[38]  Allan R. Jones,et al.  Shared and distinct transcriptomic cell types across neocortical areas , 2017, bioRxiv.

[39]  D. Tropea,et al.  Editorial: Biology of Brain Disorders , 2017, Front. Cell. Neurosci..

[40]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[41]  Grace X. Y. Zheng,et al.  Massively parallel digital transcriptional profiling of single cells , 2016, Nature Communications.

[42]  Brittany N. Lasseigne,et al.  Post-mortem molecular profiling of three psychiatric disorders , 2016, bioRxiv.

[43]  A. Singleton,et al.  Genetic and phenotypic characterization of complex hereditary spastic paraplegia , 2016, Brain : a journal of neurology.

[44]  Seth G. N. Grant,et al.  Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment , 2016, Front. Neurosci..

[45]  Núria Queralt-Rosinach,et al.  DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases , 2015, bioRxiv.

[46]  Allan R. Jones,et al.  Canonical Genetic Signatures of the Adult Human Brain , 2015, Nature Neuroscience.

[47]  Xiang Zhang,et al.  Comparative analysis of a novel disease phenotype network based on clinical manifestations , 2015, J. Biomed. Informatics.

[48]  Jes Olesen,et al.  The Cost of Brain Diseases: A Burden or a Challenge? , 2014, Neuron.

[49]  Zhicheng Lin,et al.  SLC6A3 is a risk factor for Parkinson's disease: A meta-analysis of sixteen years’ studies , 2014, Neuroscience Letters.

[50]  Allan R. Jones,et al.  Transcriptional Landscape of the Prenatal Human Brain , 2014, Nature.

[51]  Ta-Liang Chen,et al.  Psychiatric Disorders after Epilepsy Diagnosis: A Population-Based Retrospective Cohort Study , 2013, PloS one.

[52]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[53]  Joanna M Biernacka,et al.  Genetic variability in the NMDA‐dependent AMPA trafficking cascade is associated with alcohol dependence , 2012, Addiction biology.

[54]  Karen Santucci,et al.  Psychiatric disease and drug abuse , 2012, Current opinion in pediatrics.

[55]  A. Serretti,et al.  Case–control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder , 2012, International journal of psychiatry in clinical practice.

[56]  S. de Ribaupierre,et al.  Language Mapping in Temporal Lobe Epilepsy in Children: Special Considerations , 2012, Epilepsy research and treatment.

[57]  Etienne Sibille,et al.  Between destiny and disease: Genetics and molecular pathways of human central nervous system aging , 2011, Progress in Neurobiology.

[58]  Huan Cai,et al.  Therapeutic potential of vasoactive intestinal peptide and its receptors in neurological disorders. , 2010, CNS & neurological disorders drug targets.

[59]  J. Cadet,et al.  Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence. , 2010, Sleep medicine.

[60]  R. Bell,et al.  Concurrence of High-Grade Brainstem Glioma and Multiple Sclerosis , 2010, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[61]  P. Kaplan Epilepsy and obsessive-compulsive disorder , 2010, Dialogues in clinical neuroscience.

[62]  M. Owen,et al.  Genetic overlap between autism, schizophrenia and bipolar disorder , 2009, Genome Medicine.

[63]  Jing Chen,et al.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..

[64]  K. Wilhelmsen,et al.  The role of aldehyde dehydrogenase-1 (ALDH1A1) polymorphisms in harmful alcohol consumption in a Finnish population , 2008, Human Genomics.

[65]  A. Granholm,et al.  Mood, memory and movement: an age-related neurodegenerative complex? , 2008, Current aging science.

[66]  Karen I Bolla,et al.  Sleep disturbance in heavy marijuana users. , 2008, Sleep.

[67]  Peter Boesiger,et al.  Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. , 2008, Brain : a journal of neurology.

[68]  M. Ashburner,et al.  The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration , 2007, Nature Biotechnology.

[69]  Q. Li,et al.  Concurrence of glioma and multiple sclerosis , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[70]  Doron Lancet,et al.  Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification , 2005, Bioinform..

[71]  David W. Miller,et al.  Glial cell inclusions and the pathogenesis of neurodegenerative diseases. , 2004, Neuron glia biology.

[72]  N. Schork,et al.  Identifying genes and genetic variation underlying human diseases and complex phenotypes via recombination mapping , 2004, The Journal of physiology.

[73]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[74]  J. Olesen,et al.  The burden of brain diseases in Europe , 2003, European journal of neurology.

[75]  R. Ptak,et al.  Hypothalamic amnesia with spontaneous confabulations: A clinicopathologic study , 2001, Neurology.

[76]  G. Halliday,et al.  Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. , 2000, Brain : a journal of neurology.

[77]  D. Borchelt,et al.  Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems. , 1997, Revue neurologique.

[78]  I. Gozes,et al.  Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  S. Currie,et al.  Concurrence of multiple sclerosis and glioma , 1974, Journal of neurology, neurosurgery, and psychiatry.

[80]  R. Reilmann Parkinsonism in Huntington's disease. , 2019, International review of neurobiology.

[81]  Martin J. Schmidt,et al.  Neurodevelopment, GABA System Dysfunction, and Schizophrenia , 2015, Neuropsychopharmacology.

[82]  W. Mason THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES , 2014 .